Angiogenic factor levels across severity stages of fetal smallness with or without associated pre‐eclampsia
Ultrasound in Obstetrics & Gynecology · 2026-02 · 67 (2) · 147-154
DOI: 10.1002/uog.70156 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ultrasound in Obstetrics & Gynecology, online erschienen am 08.01.2026. Verfasst von L Youssef und 7 weiteren Autor:innen. Beteiligte Einrichtung: BCNatal, Barcelona Center for Maternal Fetal and Neonatal Medicine, Hospital Clínic and Hospital Sant Joan de Déu, IDIBAPS, University of Barcelona, …. Hauptthemen laut MEDLINE: Fetal Growth Retardation, Pre-Eclampsia, Placenta Growth Factor, Vascular Endothelial Growth Factor Receptor-1. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Ministerio de Educación y Ciencias, 'la Caixa' Foundation, Fondazione Comunitaria del Varesotto and Provincia di Varese.
Abstract (Originalsprache)
Objective
Angiogenic factors are elevated in fetal growth restriction (FGR), but their clinical value for assessing the severity of FGR and the potential influence of coexisting pre‐eclampsia has scarcely been investigated. In this study, our aim was to investigate the profile of maternal angiogenic factors across severity stages of fetal smallness compared with controls, analyzed overall and stratified by the presence or absence of pre‐eclampsia, and to investigate whether values of these angiogenic factors, such as placental growth factor (PlGF), soluble fms‐like tyrosine kinase‐1 (sFlt‐1) and the sFlt‐1/PlGF ratio, are helpful in determining the severity stage of fetal smallness.
Methods
This was a prospective cohort study of women with a singleton pregnancy diagnosed with fetal smallness (defined as birth weight < 10 th centile) ( n = 604) between October 2010 and December 2017, compared with a control group of pregnant women with an appropriate‐for‐gestational‐age (AGA) singleton fetus (defined as birth weight ≥ 10 th centile) ( n = 424). At diagnosis, ultrasound was performed to assess estimated fetal weight (EFW) and Doppler pulsatility indices (PI) of the uterine artery (UtA), umbilical artery (UA), fetal middle cerebral artery (MCA) and ductus venosus (DV), and these parameters were monitored regularly until delivery. Cerebroplacental ratio (CPR) was calculated as MCA‐PI/UA‐PI. Small fetuses were classified as: small‐for‐gestational age (SGA) if EFW ≥ 3 rd and < 10 th centile, with normal Doppler parameters; FGR Stage I if either EFW < 3 rd centile, persistent MCA‐PI < 5 th centile, UA‐PI > 95 th centile, CPR < 5 th centile or UtA‐PI > 95 th centile; FGR Stage II if there was absent end‐diastolic flow in the UA; FGR Stage III if there was reversed end‐diastolic flow in the UA or DV‐PI ≥ 95 th centile; or FGR Stage IV if there was non‐reassuring cardiotocography or absent/reversed DV atrial flow. Maternal peripheral venous blood concentrations of PlGF and sFlt‐1 were determined using enzyme‐linked immunosorbent assay, and the sFlt‐1/PlGF ratio was calculated. Linear trend of proportions was tested using the Mantel–Haenszel chi‐square test.
Results
Among AGA controls ( n = 424), SGA ( n = 192), FGR Stage I ( n = 380), FGR Stage II ( n = 16) and FGR Stages III–IV ( n = 16) fetuses, the proportion of cases with a sFlt‐1/PlGF ratio > 95 th centile was 12.7%, 7.8%, 30.8%, 43.8% and 62.5%, respectively ( P = 0.0001), and the median multiples of the median (MoM) values for the sFlt‐1/PlGF ratio were 0.55 (interquartile range (IQR), 0.19–2.00), 1.00 (IQR, 0.31–2.67), 3.03 (IQR, 0.91–8.20), 3.94 (IQR, 0.85–9.13) and 7.32 (IQR, 1.44–16.29), respectively ( P = 0.24). Pre‐eclampsia was diagnosed at any time between inclusion and delivery in 1.9% of controls, 3.6% of SGA, 21.1% of FGR Stage I, 37.5% of FGR Stage II and 50.0% of FGR Stages III–IV fetuses. Among all small fetuses with vs without pre‐eclampsia, the proportion of pregnancies with sFlt‐1/PlGF ratio > 95 th centile was 56.9% vs 15.4% ( P < 0.001) and the median MoM of the sFlt‐1/PlGF ratio was 8.11 (IQR, 3.83–27.09) vs 1.59 (IQR, 0.52–5.04) ( P = 0.18).
Conclusions
Serum levels of angiogenic factors became more abnormal as the severity stage of fetal smallness increased. This association with severity was stronger in the presence of pre‐eclampsia. However, absolute values of serum levels showed substantial overlap in both the presence and the absence of pre‐eclampsia, making their use in determining the severity stage of fetal smallness challenging. © 2026 International Society of Ultrasound in Obstetrics and Gynecology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- BCNatal, Barcelona Center for Maternal Fetal and Neonatal Medicine, Hospital Clínic and Hospital Sant Joan de Déu, IDIBAPS, University of Barcelona, Barcelona, Spain.
- Josep Carreras Leukaemia Research Institute, Hospital Clinic, University of Barcelona Campus, Barcelona, Spain.
- Department of Obstetrics and Gynecology, Ospedale Filippo Del Ponte, University of Insubria, Varese, Italy.
- Institut de Recerca Sant Joan de Déu (IRSJD), Fundació Sant Joan de Déu, Barcelona, Spain.
- Department of Obstetrics and Gynecology, Faculty of Medicine, Grupo de Investigación en Cuidado Intensivo y Obstetricia (GRICIO), Universidad de Cartagena, Cartagena, Colombia.
- Department of Obstetrics and Gynecology, Centro Hospitalario Serena del Mar and Fundación Santa Fe de Bogotá, Bogotá, Colombia.
ORCID-Profile: L Youssef, F Crovetto, J Miranda, S Lobmaier, F Figueras, E Gratacos
Förderung
- Ministerio de Educación y Ciencias
- 'la Caixa' Foundation
- Fondazione Comunitaria del Varesotto and Provincia di Varese
- Hospital Clinic, Barcelona
- Fundación Mutua Madrileña
- Departament de Recerca i Universitats de la Generalitat de Catalunya
- Fundació la Marató de TV3
- Instituto de Salud Carlos III
Zitieren
APA
Youssef, L., Paolucci, S., Crovetto, F., Miranda, J., Lobmaier, S., Figueras, F., Crispi, F., & Gratacos, E. (2026). Angiogenic factor levels across severity stages of fetal smallness with or without associated pre‐eclampsia. Ultrasound in Obstetrics & Gynecology, 67(2), 147-154. https://doi.org/10.1002/uog.70156
Vancouver
Youssef L, Paolucci S, Crovetto F, Miranda J, Lobmaier S, Figueras F, et al. Angiogenic factor levels across severity stages of fetal smallness with or without associated pre‐eclampsia. Ultrasound in Obstetrics & Gynecology. 2026;67(2):147-154. doi:10.1002/uog.70156
BibTeX
@article{Youssef2026,
author = {Youssef, L and Paolucci, S and Crovetto, F and Miranda, J and Lobmaier, S and Figueras, F and Crispi, F and Gratacos, E},
title = {Angiogenic factor levels across severity stages of fetal smallness with or without associated pre‐eclampsia},
journal = {Ultrasound in Obstetrics & Gynecology},
year = {2026},
volume = {67},
number = {2},
pages = {147--154},
doi = {10.1002/uog.70156}
}
EUVIMED